Wellness & Workforce Solution for Lupus/Lupus Nephritis
[2069264-1] Wellness & Workforce Solution for Lupus and Lupus Nephritis / Janssen Clinical Investigator Initiated Study
1 other identifier
interventional
160
0 countries
N/A
Brief Summary
The investigators will test the hypothesis that culturally congruent coaching delivered via a technology application (Health360x) will improve the persistent disparities observed among women of color with lupus or lupus nephritis by addressing underlying psychosocial barriers to behavioral change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedJanuary 22, 2024
January 1, 2024
5 months
December 8, 2023
January 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
engagement
frequency counts of app usage and patterns of usage will be combined to report application usage data
Baseline, 3, 6 months
goal attainment
Health360x application usage data
Baseline, 6 months
Secondary Outcomes (13)
change in systolic and diastolic blood pressure (mmHg)
Baseline, 3, 6 months
change in diet
Baseline, 6 months
change in blood glucose (mg/dL)
Baseline, 3, 6 months
change in total distance walked daily
Baseline, 3, 6 months
Health related quality of life
Baseline, 3, 6 months
- +8 more secondary outcomes
Study Arms (2)
C3 Coach plus H360x
EXPERIMENTALArm 1 will have 80 participants who will receive four weekly goal setting sessions with coach consisting of 45 min-1 hour recorded sessions. They will then receive another 4 sessions every 2 weeks, followed by three monthly goal setting sessions. Baseline surveys will be collected, in addition to surveys taken at 3 and 6 months.
C3 Coach plus Health360x and micro-learning
ACTIVE COMPARATORArm 2 will have 80 participants who will receive four weekly goal setting sessions with coach consisting of 45 min-1 hour recorded sessions, in addition to periodic micro-learning content delivered via an online technology platform. They will then receive another 4 sessions every 2 weeks, followed by three monthly goal setting sessions. Baseline surveys will be collected, in addition to surveys taken at 3 and 6 months. This arm will have learning augmented by micro-learning to test effectiveness in enhancing engagement and promoting retention of educational content.
Interventions
This is a series of modules designed to provide disease education, additional communication through 'push notifications,' promote self-management, and medication adherence in women of color with lupus and lupus nephritis. Leveraging technology, this program is asynchronous, promotes engagement and retention of information through micro-learning, and allows the investigators to better understand patient experiences beyond structured surveys by capturing what is happening in the patient-coach relationship.
The coach and participant will use problem-solving tools embedded in Health360x to map out potential barriers to goal attainment and create goal action plans. This application has the potential to help improve health-related quality of life, and reduce morbidity and mortality associated with Lupus. The intervention also tests the role of health coaches in the lupus ecosystem. The potential economic gain and impact on more extant social determinants of health can create long ranging benefits on the health and wellbeing of the community.
The coaching process includes specified visits over the course of our proposed 6-month intervention. These visits will occur remotely using HIPAA compliant video conferencing tools or in person when it is safe and convenient to meet in person. Overall, the coaches will work with Lupus patients to facilitate experiential learning, improve functioning and performance in the context of working towards specific goals.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- females ; Age over 18yo
- Self-reported diagnosis of Lupus or Lupus Nephritis, or documented diagnosis of Lupus or Lupus Nephritis
- Willingness to adhere to the study intervention regimen
- Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart-phone, internet access)
- Not currently practicing self-management behaviors and have not participated in a class or program on self-management behavior within the last 12 months
- Adult women with lupus and lupus nephritis will be enrolled in the study. Eligibility: Adult women with lupus and lupus nephritis who are able to consent and participate in self-management support training. Access to the internet is required for this intervention. Ability to read English is required because all the materials are currently in English.
- Coaches must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for duration of study
- Women of color with lupus or lupus nephritis with desire to help others
- Ability to communicate in English
- Secure access to Internet
- Private space for conducting participant visits
- +1 more criteria
You may not qualify if:
- Potential participants and coaches who are unable to speak or read English, access the internet, or complete data collection activities will be ineligible for participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Morehouse School of Medicinelead
- Janssen Scientific Affairs, LLCcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Priscilla Pemu, MD
MSM Director of Clinical Research Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2023
First Posted
January 22, 2024
Study Start
June 1, 2024
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
January 22, 2024
Record last verified: 2024-01